We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines, and consumer healthcare.

In March 2015 we completed a three-part transaction with Novartis which reshapes our business. We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. In addition, Novartis acquired our marketed Oncology portfolio and the R&D activities related to it. 

As the integration of this business units progresses, this website will be updated to reflect the expanded portfolio of vaccines. 

To report any adverse event related to a GSK pharmaceutical product, please see information on the Contact us page.